Inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, comprises a group of multifactorial disorders of unknown etiology but has a high incidence that is widely distributed throughout the human population.1) Although the etiology of IBD is not clear at present, recent studies suggest that IBD is a disorder involving activation of leukocytes (macrophages, lymphocytes, and neutrophils) and their infiltration into the inflamed intestine. [2][3][4][5] Enhanced endoplasmic reticulum (ER) stress has been implicated in various pathological situations including inflammation. Several reports have shown that the ER stress response is induced in association with the development of IBD. Bertlotti et al. 6) reported that when dextran sulfate sodium (DSS) was administered to mice deficient in the eukaryotic inositol-requiring transmembrane kinase-endoribonuclease-1b (IRE1b) gene to induce colitis, the time to onset was shorter (early onset) than that in the wild species. The IRE1b gene is known to be involved in signal transmission in ER stress. In addition, Kaser et al. 7) reported that the transcription factor X-box binding protein 1 (XBP1), which is an important key to ER stress response, is involved in the genetic risk of onset of IBD in humans. These findings suggest a possible correlation between IBD and ER stress.We reported that dantrolene, an antagonist of ryanodine receptors in the ER, and some antioxidants such as a-tocopherol, partly prevented tunicamycin-induced cell death in F9 homocystein-induced ER protein null cells.8) Using this cell line, our group and others have reported that 103 plantderived compounds 9,10) and 200 synthetic compounds including dibenzoylmethane (DBM) derivatives, 11) carbazole derivatives, 12) and pyrimidine derivatives were screened previously, and some DBM derivatives improved cell viability after tunicamycin treatment at a level similar to that achieved by dantrolene in F9 Herp null cells.11) However, it remains unclear whether DBM derivatives that have protective effects against ER stress are effective against colitis.Nuclear factor kB (NF-kB) is a dimeric transcription factor that induces the expression of genes involved in the inflammatory process. Activation of NF-kB has been observed in the mucosa of patients with ulcerative colitis, 13) and butyrate has been shown to inhibit NF-kB activation in lamina propia macrophages of patients with ulcerative colitis.14) Previously, our group reported that HeLa NF-kB -3 cells, which are stable transformants with a NF-kB response element, obtained a reporter gene. These cells showed an approximately 6-fold higher activation of NF-kB with tumor necrosis factor alpha (TNF-a) stimulation. Moreover, some DBM derivatives inhibited NF-kB activity.15) However, it remains unclear whether DBM derivatives that have NF-kB inhibitory activity are effective against colitis.Zhang and Kaufman suggest that an enhanced ER stress response contributed to the progression of inflammation through the activation of NF-kB.
16)T...